BRAF and thyroid gland disorder: This mutation occurs in the majority of cases and results in the constitutively activated BRAF kinase [11], which plays a fundamental role in thyroid tumorigenesis through driving Ras/Raf/MEK/ERK (MAPK) signaling pathway [10,11].